IDEA Collider IDEA Pharma

In this engaging conversation, we delve into the world of pharmaceutical innovation and collaboration. Our guest, Dr. Nedim Pipic, a pharmaceutical expert specializing in mental and retinal health, shares his journey and passion for making a difference.

Quitting is a valuable skill. It’s important for dealing with uncertainty, yet we are quite bad at exercising it. It should not be just about sticking to things. Quitting is also good, particularly when we have to start most things. Persisting at something when it’s worthwhile is definitely a good character trait but persisting at something when it’s no longer worthwhile is not a good character trait. Calibrate around the notion, “is it worthwhile to stick? "

The speed of Recursion is remarkable in delivering a value proposition. Michael Secora, Chief Financial Officer at Recursion, expounds on data relatability, building various data sets, and leveraging data sets to build a next-generation biopharmaceutical company! Moreover, he shares tips on standing out amongst competitors and what differentiates Recursion from other AI discovery companies.